Regional immunotherapy in resectable squamous cell lung carcinoma
β Scribed by N. Roeslin; J. M. Lang; G. Morand; J. M. Wihlm; J. P. Witz
- Publisher
- Springer-Verlag
- Year
- 1982
- Tongue
- English
- Weight
- 173 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
mg/kg daily) or a placebo was given in a randomized, double-blind study to 211 patients undergoing curative surgery for primary lung cancer. The treatment, in a fixed dose of one tablet (containing 50 mg or a placebo) t.i.d., was given for 3 clays before the operation, and such 3-day courses were re
## Abstract ## Objectives: The tonsillar fossa is the most common subsite of the oropharynx to be afflicted with squamous cell carcinoma (SCCA). Accepted treatments include any combination of surgery, radiotherapy, and chemotherapy. We review the oncologic and functional outcomes of patients with
## Abstract Cytogenetic analysis of a squamous cell lung carcinoma revealed a nearβhaploid karyotype with 27 chromosomes, in both primary cultures and an established cell line. The only chromosomes with two homologs present were chromosomes X, 5, 7, and 22. The two X chromosomes were early and late